Directorate Change

RNS Number : 4784J
Omega Diagnostics Group PLC
30 June 2011
 



30 June 2011                                                                                                                                                                              AIM: ODX

 

Omega Diagnostics Group PLC

("Omega" or "the Company")

 

Directorate Change

 

Omega, the AIM listed medical diagnostics company, announces that Jag Grewal will join the Board as an Executive Director with immediate effect.

 

Jag Grewal, aged 42, joined the Company on 6 June 2011 as Group Sales and Marketing Director. Jag has worked in diagnostics for over 20 years having started out as a Clinical Biochemist in the NHS. In 1995, he joined Beckman Instruments where he developed a career spanning 15 years in sales and marketing holding a variety of positions in sales, product management and marketing management. 

 

In 2009, Jag left as Northern Europe Marketing Manager to join Serco Health where he helped create the first joint venture within UK pathology between Serco Health and Guys and St Thomas' Hospital NHS Foundation Trust. Jag is also past Chairman and current treasurer of the British In-Vitro Diagnostics Association (BIVDA).

 

Andrew Shepherd, the Company's Chief Executive said: "We are very pleased to welcome Jag to the Board and his wealth of experience will be beneficial as we expand the scale of the Group's sales and marketing function in line with our expansion plans."

 

 

For further enquiries please contact:

 

Omega Diagnostics Group PLC                         

Tel: 01259 763 030

Andrew Shepherd, Chief Executive                             


Kieron Harbinson, Group Finance Director                                                      

www.omegadiagnostics.com



Cenkos Securities plc                                               

Tel: 020 7397 8900

Ian Soanes

Elizabeth Bowman




Walbrook PR Limited


Paul McManus

Tel: 020 7933 8787

Mob: 07980 541 893

paul.mcmanus@walbrookpr.com

Fiona Henson

Tel: 020 7933 8795


Mob: 07886 335 992


fiona.henson@walbrookpr.com

 

 



 

Additional information:

 

Jag Grewal, aged 42, holds no shares in the Company and other than as set out below, there is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of Mr Grewal's appointment today as a Director of the Company.

 

Mr Grewal is a director / partner or has been a director / partner of the following companies / partnerships during the previous five years:

 

British In-Vitro Diagnostics Association


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAWGUQGQUPGGPU
UK 100

Latest directors dealings